A research team at Lund University in Sweden has discovered a certain type of cell—foam cells—in patients with the aggressive ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

Phase 3 trial results showed that adding veliparib to temozolomide did not significantly improve overall or progression-free survival in newly diagnosed, MGMT-hypermethylated glioblastoma.

The initial trio of patients with glioblastoma have begun treatment with ropidoxuridine in a phase 2 clinical trial, ...

A new clinical trial for patients with recurrent glioblastoma brain cancer has opened at UCLH, with leadership and support ...

CureVac (CVAC) announced that new and updated data will be shared in two oral presentations and four posters at the 12th International mRNA ...

Now there is hope after researchers developed a new imaging technique which can help spot which patients will benefit from ...

CNS Pharmaceuticals (NASDAQ: CNSP) , focused on innovative cancer therapies for brain and central nervous system cancers, recently participated in ...